RemeGen Sets 29 October 2026 Board Meeting to Approve Q3 and 9-Month 2026 Results

Bulletin Express10-16

RemeGen Co., Ltd. has scheduled a board meeting for 29 October 2026 to review and approve the unaudited financial results for the third quarter and the nine months ended 30 September 2026. The company also plans to authorize the public release of these figures after the meeting.

The board currently comprises five executive directors—Chairman Wang Weidong, Fang Jianmin, Wen Qingkai, Fang Michelle Yi and Wang Yuxiao—one non-executive director, Wang Liqiang, and three independent non-executive directors, Song Xiliang, Huang Guobin and Chen Yunjin.

The announcement was released in Yantai, the People’s Republic of China, on 16 October 2026. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for its accuracy or completeness.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment